The effect of two types of exercise on some predictors of cardiovascular status in overweight men

The effect of eight weeks of high intensity interval and continuous training on galectin 3, GDF15, NT-ProBNP and IL6 in overweight men

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201108049299N1

Enrollment

Registered

2020-12-06

Start date

2019-09-24

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight. Overweight

Interventions

Intervention 1: Intervention group 1: High intensity interval training with three sessions of interval training protocol each week for eight weeks. Intervention 2: Intervention group 2: Continuous tra

Eligibility

Sex/Gender

Male

Age

23 Years to 28 Years

Inclusion criteria

Inclusion criteria: Age range between 23 and 28 BMI between 25 and 30 Male gender

Exclusion criteria

Exclusion criteria: No history of known cardiovascular, hepatic, renal, pulmonary and diabetic diseases, hypothyroidism No serious physical injury and orthopedics Do not take food and medicine supplements no regular exercise in the year leading up to the study

Design outcomes

Primary

Measure	Time frame
Galectin 3. Timepoint: Two days before the start of the study and two days after the end of the study (eight weeks of study). Method of measurement: Blood draw from arm vein and laboratory kit of galectin 3.;Interleukin 6. Timepoint: Two days before the start of the study and two days after the end of the study (eight weeks of study). Method of measurement: Blood draw from arm vein and laboratory kit of Interleukin6.;NT-ProB-Type Natriuretic Peptide (BNP). Timepoint: Two days before the start of the study and two days after the end of the study (eight weeks of study). Method of measurement: Blood draw from arm vein and laboratory kit of NT-ProBNP.;Growth Differentiation Factor-15 (GDF15). Timepoint: Two days before the start of the study and two days after the end of the study (eight weeks of study). Method of measurement: Blood draw from arm vein and laboratory kit of GDF15.	—

Measure

Time frame

Galectin 3. Timepoint: Two days before the start of the study and two days after the end of the study (eight weeks of study). Method of measurement: Blood draw from arm vein and laboratory kit of galectin 3.;Interleukin 6. Timepoint: Two days before the start of the study and two days after the end of the study (eight weeks of study). Method of measurement: Blood draw from arm vein and laboratory kit of Interleukin6.;NT-ProB-Type Natriuretic Peptide (BNP). Timepoint: Two days before the start of the study and two days after the end of the study (eight weeks of study). Method of measurement: Blood draw from arm vein and laboratory kit of NT-ProBNP.;Growth Differentiation Factor-15 (GDF15). Timepoint: Two days before the start of the study and two days after the end of the study (eight weeks of study). Method of measurement: Blood draw from arm vein and laboratory kit of GDF15.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Moradi

The University of Tehran

m.moradi13@ut.ac.ir+98 41 4422 9447

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026